Cyanosis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (9 intermediate revisions by 2 users not shown) | |||
| Line 2: | Line 2: | ||
{{Cyanosis}} | {{Cyanosis}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{Sara.Zand}} | ||
==Overview== | ==Overview== | ||
The prevalence of congenital heart disease is approximately 1000 per 100,000 individuals worldwide. Data about the incidence of [[cyanotic]] [[congenital heart disease]] is inadequate. [[Congenital cyanotic heart disease]] is more commonly observed among neonates. [[Congenital cyanotic heart disease]] affects men and women equally. There is no racial predilection for [[cyanotic congenital heart disease]]. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
* | *The prevalence of [[congenital heart disease]] is approximately 1000 per 100,000 individuals worldwide.<ref name="StoutDaniels2019">{{cite journal|last1=Stout|first1=Karen K.|last2=Daniels|first2=Curt J.|last3=Aboulhosn|first3=Jamil A.|last4=Bozkurt|first4=Biykem|last5=Broberg|first5=Craig S.|last6=Colman|first6=Jack M.|last7=Crumb|first7=Stephen R.|last8=Dearani|first8=Joseph A.|last9=Fuller|first9=Stephanie|last10=Gurvitz|first10=Michelle|last11=Khairy|first11=Paul|last12=Landzberg|first12=Michael J.|last13=Saidi|first13=Arwa|last14=Valente|first14=Anne Marie|last15=Van Hare|first15=George F.|title=2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines|journal=Circulation|volume=139|issue=14|year=2019|issn=0009-7322|doi=10.1161/CIR.0000000000000603}}</ref> | ||
* | * Data about the incidence of [[cyanotic congenital heart disease]] is inadequate. | ||
* | |||
* [[ | ===Age=== | ||
* | *[[Congenital cyanotic heart disease]] is more commonly observed among neonates. | ||
===Gender=== | |||
*[[Congenital cyanotic heart disease]] affects men and women equally. | |||
===Race=== | |||
*There is no racial predilection for [[cyanotic]] [[congenital heart disease]]. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Primary care]] | |||
[[Category: | |||
Latest revision as of 04:08, 26 December 2020
|
Cyanosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cyanosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Cyanosis epidemiology and demographics |
|
Risk calculators and risk factors for Cyanosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2]
Overview
The prevalence of congenital heart disease is approximately 1000 per 100,000 individuals worldwide. Data about the incidence of cyanotic congenital heart disease is inadequate. Congenital cyanotic heart disease is more commonly observed among neonates. Congenital cyanotic heart disease affects men and women equally. There is no racial predilection for cyanotic congenital heart disease.
Epidemiology and Demographics
- The prevalence of congenital heart disease is approximately 1000 per 100,000 individuals worldwide.[1]
- Data about the incidence of cyanotic congenital heart disease is inadequate.
Age
- Congenital cyanotic heart disease is more commonly observed among neonates.
Gender
- Congenital cyanotic heart disease affects men and women equally.
Race
- There is no racial predilection for cyanotic congenital heart disease.
References
- ↑ Stout, Karen K.; Daniels, Curt J.; Aboulhosn, Jamil A.; Bozkurt, Biykem; Broberg, Craig S.; Colman, Jack M.; Crumb, Stephen R.; Dearani, Joseph A.; Fuller, Stephanie; Gurvitz, Michelle; Khairy, Paul; Landzberg, Michael J.; Saidi, Arwa; Valente, Anne Marie; Van Hare, George F. (2019). "2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". Circulation. 139 (14). doi:10.1161/CIR.0000000000000603. ISSN 0009-7322.